Literature DB >> 19410718

Rescuing the bottom billion through control of neglected tropical diseases.

Peter J Hotez1, Alan Fenwick, Lorenzo Savioli, David H Molyneux.   

Abstract

Mesh:

Year:  2009        PMID: 19410718     DOI: 10.1016/S0140-6736(09)60233-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  322 in total

1.  Parasitic infections, anemia and malnutrition among rural settled and mobile pastoralist mothers and their children in Chad.

Authors:  M Bechir; E Schelling; M A Hamit; M Tanner; J Zinsstag
Journal:  Ecohealth       Date:  2011-12-13       Impact factor: 3.184

2.  Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians.

Authors:  Courtney Ek; Mark T Whary; Melanie Ihrig; Luis E Bravo; Pelayo Correa; James G Fox
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

3.  Prevention and schizophrenia--the role of dietary factors.

Authors:  John McGrath; Alan Brown; David St Clair
Journal:  Schizophr Bull       Date:  2010-10-25       Impact factor: 9.306

Review 4.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Authors:  Peter J Hotez; Jeffrey M Bethony; David J Diemert; Mark Pearson; Alex Loukas
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

5.  A quarter century of progress in paediatric clinical pharmacology: A personal view.

Authors:  Stuart M MacLeod
Journal:  Br J Clin Pharmacol       Date:  2015-11-10       Impact factor: 4.335

6.  Neglected tropical diseases: operational research for elimination and control.

Authors:  Johan van Griensven
Journal:  Public Health Action       Date:  2012-09-21

7.  Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of Retnla expression and secretion.

Authors:  Martha Truscott; D Andrew Evans; Matt Gunn; Karl F Hoffmann
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.

Authors:  Peter D Ziniel; Janish Desai; Cynthia L Cass; Craig Gatto; Eric Oldfield; David L Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection.

Authors:  Ayola A Adegnika; Jeannot F Zinsou; Saadou Issifou; Ulysse Ateba-Ngoa; Roland F Kassa; Eliane N Feugap; Yabo J Honkpehedji; Jean-Claude Dejon Agobe; Hilaire M Kenguele; Marguerite Massinga-Loembe; Selidji T Agnandji; Benjamin Mordmüller; Michael Ramharter; Maria Yazdanbakhsh; Peter G Kremsner; Bertrand Lell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

10.  Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays.

Authors:  Stephanie Howe; Dorina Zöphel; Harini Subbaraman; Clemens Unger; Jana Held; Thomas Engleitner; Wolfgang H Hoffmann; Andrea Kreidenweiss
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.